10x Genomicsの収益Y / Y
10x Genomicsの収益Y / Yは何ですか。
10x Genomics, Inc.の収益Y / Yは11.14%です。
収益Y / Yの定義は何ですか。
過去3年間の年間収益の伸びは、過去3年間で平均した1年間の収益成長率です。
The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.
NASDAQのセクタHealth Careにおける収益Y / Yの企業と比べる10x Genomics
10x Genomicsは何をしますか。
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
10x Genomicsと類似の収益y / y
- Bumble Class A Common Stockの収益Y / Yは11.11%です。
- Jernigan Capitalの収益Y / Yは11.12%です。
- Linc Pen & Plasticsの収益Y / Yは11.12%です。
- RattanIndia Powerの収益Y / Yは11.13%です。
- Armstrong Flooring Incの収益Y / Yは11.13%です。
- abrdn Asia-Pacific Income Fund Incの収益Y / Yは11.14%です。
- 10x Genomicsの収益Y / Yは11.14%です。
- Silvercorp Metalsの収益Y / Yは11.14%です。
- Gongniu Coの収益Y / Yは11.14%です。
- Indian Overseas Bankの収益Y / Yは11.15%です。
- Argoの収益Y / Yは11.16%です。
- China Digital Culture ()の収益Y / Yは11.18%です。
- Andritz AGの収益Y / Yは11.19%です。